USA flag logo/image

An Official Website of the United States Government

Online Buprenorphine Training for Outreach Workers and Case Managers

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
95961
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
DA027247
Solicitation Year:
N/A
Solicitation Topic Code:
NIDA
Solicitation Number:
N/A
Small Business Information
SOCIAL SCIENCES INNOVATIONS CORPORATION
71 W 23RD ST, 8TH FL NEW YORK, NY -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: Online Buprenorphine Training for Outreach Workers and Case Managers
Agency: HHS
Contract: 1R43DA027247-01A1
Award Amount: $124,075.00
 

Abstract:

DESCRIPTION (provided by applicant): We propose to develop a low-cost, easily accessible, online training curriculum about buprenorphine treatment for outreach workers and case managers whose responsibilities include locating, motivating, educating, and/or referring to drug treatment youth and adults dependent upon heroin and other opiates. Increasing enrollment in treatment for heroin and other opioid dependency is critically needed. Recent estimates place the population of heroin and other opiate-dependen t users in the U.S. at 980,000 -- the highest number since the late 1970's. These numbers have risen across all sociodemographic groups, and have doubled among youth. The abuse of prescribed opiates such as OxyContin(R) and Vicodin(R) has risen remarkably in recent years and the injection of heroin and other drugs (often in combination with heroin) continues to be associated with one-third of all new HIV cases and the majority of HCV cases in the U.S. Yet, only 20 percent of opiate-dependent drug users in n eed of treatment are actually enrolled in treatment. Fortunately, new legislation enacted in 2000 by Congress has dramatically changed the way opiate dependency can be treated in the U.S. The Drug Addiction Treatment Act permits qualified physicians to tre at opiate dependency with drugs approved by the FDA. After nearly two decades of NIDA-sponsored research and clinical trials, a new drug, buprenorphine, was introduced in 2002. Medication-assisted treatment with buprenorphine holds the potential to revolut ionize the treatment of opioid dependency by increasing access to and enrollment in drug treatment. However, in order to increase access and enrollment, it is necessary to address a number of barriers, including the knowledge gap regarding this new medicat ion. While physicians and addiction professionals can easily access training online, no such training exists for outreach workers and case managers-- the frontline workers who are often the first contact with hard-to-reach opiate dependent youth and adul ts (including many ethnic minorities). The online training curriculum will include relevant information on the use of buprenorphine for special populations (e.g. youth, HIV+ persons). In Phase I, we will: (1) develop the curriculum in a Computer Assisted I nstruction (CAI) format; (2) create a self-directed and interactive prototype of two CAI modules; and (3) evaluate the computerized prototype of the two modules. The curriculum will be marketed to a broad range of profit and non-profit organizations and in stitutions.

Principal Investigator:

Janie E. Simmons
2128454400
SIMMONS@NDRI.ORG

Business Contact:

Lisa Bernhard
bernhard@ndri.org
Small Business Information at Submission:

SOCIAL SCIENCES INNOVATIONS CORPORATION
SOCIAL SCIENCES INNOVATIONS CORP 71 W 23RD ST, 8TH FL NEW YORK, NY 10010

EIN/Tax ID: 114174378
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No